Pennant Group Files 8-K for Disclosure and Exhibits

Ticker: PNTG · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1766400

Sentiment: neutral

Topics: disclosure, financial-statements, exhibits

TL;DR

Pennant Group filed a routine 8-K for disclosures and exhibits, no major news.

AI Summary

Pennant Group, Inc. filed an 8-K on March 12, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for these sections.

Why It Matters

This filing serves as a standard notification to the SEC regarding regulatory disclosures and financial statements, providing transparency to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, indicating no immediate material changes or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Pennant Group, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on March 12, 2024.

In which state is Pennant Group, Inc. incorporated?

Pennant Group, Inc. is incorporated in Delaware.

What is the address of Pennant Group, Inc.'s principal executive offices?

The address of Pennant Group, Inc.'s principal executive offices is 1675 E Riverside Drive, Suite 150, Eagle, ID 83616.

Does this filing indicate any specific material events or financial performance changes?

This filing does not specify any particular material events or financial performance changes; it primarily covers Regulation FD Disclosure and Financial Statements and Exhibits.

Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-03-12 12:49:29

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. A copy of the Company's press release announcing the participation in the 2024 Oppenheimer Healthcare MedTech & Services Conference is furnished as Exhibit 99.1 to the Current Report on Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of the Company dated March 12, 2024. 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 12, 2024 THE PENNANT GROUP, INC. By: /s/ BRENT J. GUERISOLI Brent J. Guerisoli Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing